Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01000558 · ClinicalTrials.gov registry record
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
A clinical trial of Lymphoma, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 939
- Enrollment target
- 20
- Study locations
NCT01000558: Completed study of Lymphoma, sponsored by SWOG Cancer Research Network.
NCT01000558 is a study of Lymphoma that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 939 participants, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (95% higher). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01000558, a study of Lymphoma, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 939 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
Georgia
- Piedmont Hospital - Atlanta
- Northside Hospital Cancer Center - Atlanta
- Saint Joseph's Hospital of Atlanta - Atlanta
- CCOP - Atlanta Regional - Atlanta
- WellStar Cobb Hospital - Austell
- John B. Amos Cancer Center - Columbus
- Charles B. Eberhart Cancer Center at DeKalb Medical Center - Decatur
- Piedmont Fayette Hospital - Fayetteville
California
- Alta Bates Summit Comprehensive Cancer Center - Berkeley
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center - Burbank
- Peninsula Medical Center - Burlingame
- North Bay Cancer Center - Fairfield
- California Pacific Medical Center - California Campus - San Francisco
- Sutter Health - Western Division Cancer Research Group - San Rafael
- Sutter Solano Medical Center - Vallejo
Alabama
- Providence Cancer Center at Providence Hospital - Mobile
Alaska
- Alaska Regional Hospital Cancer Center - Anchorage
Arkansas
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith
Connecticut
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford
Florida
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 939 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-07 |
What the finished NCT01000558 record still lists
NCT01000558 is an observational study that tracks outcomes without assigning an intervention. The registered 939 participants enrollment target is mid-sized for trials with a published cap, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (95% higher).
The record links to 1 condition, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT01000558 names 20 study sites across 7 states, led by Georgia, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT01000558 about?
NCT01000558 is a clinical study titled "SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma". RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.
What is the current status of trial NCT01000558?
This trial is currently completed. The enrollment target is 939 participants. The study started on 2005-03. Estimated completion is 2011-07.
What conditions does trial NCT01000558 study?
This clinical trial studies the following conditions: Lymphoma.
What interventions are being tested in trial NCT01000558?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT01000558?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01000558 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01000558's enrollment target sits among peer trials
939 8th of 299 higher than 292 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia